这一不断攀升的数字让各国卫生系统面临严峻考验。据英国糖尿病协会估计，英国国民医疗服务体系每年在糖尿病方面的开支为140亿英镑（约合人民币1195亿元），占其预算的10%。糖尿病可引发截肢、失明等严重的并发症，因此患者需要接受监测、治疗和护理。

The study was carried out by scientists funded by the pharmaceutical company Novo Nordisk, which makes diabetes treatments, together with the Steno Diabetes Centre in Gentofte, Denmark, and University College London. They say that to prevent type 2 diabetes rates rising above 10%, obesity levels must come down by a quarter.

这项研究由制药公司诺和诺德资助，该公司与位于丹麦根措夫特的Steno糖尿病中心和伦敦大学学院合作，提供糖尿病的治疗方案。他们认为，为了防止2型糖尿病的发病率上升到10%以上，肥胖症患者必须减少1/4。

“The global prevalence of obesity and diabetes is projected to increase dramatically unless prevention of obesity is significantly intensified. Developing effective global programs to reduce obesity offer the best opportunity to slow or stabilize the unsustainable prevalence of diabetes. The first step must be the recognition of the challenge that obesity presents and the mobilization of social service and disease prevention resources to slow the progression of these two conditions,” said Dr Alan Moses of Novo Nordisk Research and Development in Søborg, Denmark.

【到2045年，全球1/4的人将患肥胖症，1/8的人将2型患糖尿病】相关文章：

★ BBC总裁恩特威斯尔辞职

★ 伊索寓言——狼 和 羊

★ 现金流：投资企业的关键

★ BAE与EADS联姻告吹

★ 希腊财长：明年将是“生死攸关”的一年

★ 印度领导力大断电 12亿人受影响

★ 2013年全球IPO市场将会回暖

★ 逾400内地孕妇赴港产子后被判监禁

★ Lex专栏：瑞银已没有犯错空间

★ 专栏：下任总统，祝你好运